References for: SUBJECT

Full identifier: http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the corticosteroid dexamethasone
Eva Zegelaar
2021-12-16T20:16:56.165Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the corticosteroid dexamethasone
Eva Zegelaar
2021-12-16T20:16:54.908Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the corticosteroid dexamethasone
Eva Zegelaar
2021-12-16T20:16:53.585Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the corticosteroid dexamethasone
Eva Zegelaar
2021-12-16T20:16:52.286Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:14.585Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:13.151Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:11.701Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:10.255Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:08.786Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex )
Eva Zegelaar
2021-12-16T20:14:07.312Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:13:14.136Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:13:12.541Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:13:10.605Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:12:31.441Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
Treatment with dexamethasone
Eva Zegelaar
2021-12-16T20:12:30.122Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the anti-inflammatory drugs methyl prednisolone and dexamethasone
Eva Zegelaar
2021-12-16T20:12:28.814Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the anti-inflammatory drugs methyl prednisolone and dexamethasone
Eva Zegelaar
2021-12-16T20:12:27.327Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the anti-inflammatory drugs methyl prednisolone and dexamethasone
Eva Zegelaar
2021-12-16T20:12:25.815Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
the anti-inflammatory drugs methyl prednisolone and dexamethasone
Eva Zegelaar
2021-12-16T20:12:24.218Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex)-target complexes
Eva Zegelaar
2021-12-16T20:09:16.820Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone ( Dex)-target complexes
Eva Zegelaar
2021-12-16T20:09:14.970Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:55.863Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:54.102Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:52.563Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:50.799Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:49.021Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:08:47.405Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
After hypoxemia ( late dexamethasone group
Eva Zegelaar
2021-12-16T20:04:53.146Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
After hypoxemia ( late dexamethasone group
Eva Zegelaar
2021-12-16T20:04:51.797Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
After hypoxemia ( late dexamethasone group
Eva Zegelaar
2021-12-16T20:04:50.554Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
After hypoxemia ( late dexamethasone group
Eva Zegelaar
2021-12-16T20:04:49.299Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
After hypoxemia ( late dexamethasone group
Eva Zegelaar
2021-12-16T20:04:48.032Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
either dexamethasone or methylprednisolone
Eva Zegelaar
2021-12-16T20:04:46.741Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
either dexamethasone or methylprednisolone
Eva Zegelaar
2021-12-16T20:04:45.474Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
either dexamethasone or methylprednisolone
Eva Zegelaar
2021-12-16T20:04:44.115Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
Eva Zegelaar
2021-12-16T20:04:29.879Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
Eva Zegelaar
2021-12-16T20:04:28.665Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
Eva Zegelaar
2021-12-16T20:04:27.422Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
Eva Zegelaar
2021-12-16T20:04:26.177Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:24.941Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:23.695Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:22.302Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:20.932Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:19.146Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
using the 8 mg dexamethasone administered orally before the procedure
Eva Zegelaar
2021-12-16T20:04:17.725Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:48.783Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:47.244Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:45.996Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:44.752Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:43.434Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:42.012Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:40.447Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:39.205Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:37.799Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:36.570Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:35.328Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
low-dose dexamethasone
Eva Zegelaar
2021-12-16T20:03:34.074Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:51.479Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:49.469Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:47.566Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:45.911Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:44.035Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:42.575Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone-based regimens
Eva Zegelaar
2021-12-16T20:02:40.989Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:02:19.221Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:02:17.822Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:00:37.911Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T20:00:36.621Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:24.176Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:22.612Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:21.063Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:19.234Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:17.227Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:15.758Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:14.149Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
dexamethasone
Eva Zegelaar
2021-12-16T19:59:12.642Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:11.220Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:09.305Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:07.616Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:05.405Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:03.853Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:01.706Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:59:00.024Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:58.096Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:56.051Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:54.680Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:52.857Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:51.131Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:49.480Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:47.002Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:45.523Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:43.891Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:42.302Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:40.778Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:39.186Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:37.744Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:36.003Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:34.592Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:33.080Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
SUBJECT
use of intravenous dexamethasone plus standard care compared with standard care alone
Eva Zegelaar
2021-12-16T19:58:31.278Z
Showing 1 to 100 of 1000
<< 1 2 3 4 5 6 7 8 9 10 >>